2020 ACC/AHA Clinical Performance and Quality Measures for Adults With Heart Failure
Population
Adults with heart failure
Design
Guideline
Authors
Discussion
Loading...
Member takes
Implication
May support standardized risk assessment in HF performance measures; leaves open outcome impact in routine practice.
Key Points
- To update standardized clinical performance and quality measures for healthcare systems and clinicians treating adult patients with heart failure.
- Convened an American College of Cardiology and American Heart Association task force to review contemporary heart failure clinical guidelines.
- Evaluated evidence-based interventions spanning outpatient and inpatient care settings to identify measurable clinical processes and patient outcomes.
- Categorized metrics into performance measures suitable for public reporting and quality measures intended for internal clinical quality improvement.
- Established comprehensive metrics emphasizing guideline-directed medical therapy, including beta-blockers, renin-angiotensin system inhibitors, and mineralocorticoid receptor antagonists.
- Defined structural and procedural standards for documentation of left ventricular ejection fraction and monitoring of laboratory parameters.
- Standardized targets for post-discharge transitional care planning, patient self-care education, and symptom assessment to reduce preventable hospital readmissions.
Structured PICO
P
Population
Adults with heart failure
Provides the 2020 ACC/AHA clinical performance and quality measures for the management of adults with heart failure.
Cite This Study
Heidenreich et al. (2020) studied this question.